Adaptyv Bio is a biotechnology startup that leverages artificial intelligence (AI) to design innovative proteins that can repair damage in our bodies before it turns into a disease. The company operates in the biotech and healthcare market, serving clients who require novel protein designs for various applications such as antibodies, enzymes, or entirely new creations.

Adaptyv Bio's business model revolves around the use of AI and cell-free synthetic biology to streamline protein expression. This process allows the company to synthesize thousands of designed proteins on demand. The data generated from this process is then used to augment the AI models, optimizing the functional profile of the next set of protein designs.

The company's revenue is generated through the creation and sale of these designed proteins. Adaptyv Bio's automated workcells can profile the protein designs for a range of functions and interactions, generating high-quality experimental data that is valuable to their clients.

Adaptyv Bio is also developing a foundry that is designed to integrate with AI at every step of the protein engineering cycle. This includes designing sequences, planning experimental protocols, running experiments autonomously, and tracking all data and metadata. This innovative approach to biology is set to revolutionize the industry.

Keywords: Biotechnology, Artificial Intelligence, Protein Design, Synthetic Biology, Healthcare, Protein Expression, Automated Workcells, Experimental Data, Protein Engineering, Foundry.